Myeloid-derived suppressor cells exacerbate poly(I:C)-induced lung inflammation in mice with renal injury and older

Zhiqi Xie1,2, Haoyang Zhou2, Masanori Obana3,4,5,6

  • 1Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China.

Frontiers in Immunology
|October 11, 2023
PubMed

Insights

Myeloid-derived suppressor cells (MDSCs) worsen viral pneumonia severity. Reducing MDSCs eased lung inflammation in mice with kidney injury or in older mice, suggesting new therapeutic targets.

Area of Science:

  • Immunology
  • Pulmonology
  • Pathology

Background:

  • Viral pneumonia poses a significant global health risk, particularly for the elderly and those with pre-existing conditions.
  • Myeloid-derived suppressor cells (MDSCs) are elevated in vulnerable populations, but their specific role in viral pneumonia progression is not well understood.

Purpose of the Study:

  • To investigate the role of myeloid-derived suppressor cells (MDSCs) in exacerbating lung inflammation during viral pneumonia.
  • To determine if MDSCs contribute to increased severity in older mice or those with renal ischemia/reperfusion (I/R) injury.

Main Methods:

  • Utilized a mouse model of viral pneumonia induced by intranasal polyinosinic-polycytidylic acid (poly(I:C)) administration.
  • Examined MDSC levels in mice with renal I/R injury and in aged mice compared to controls.
  • Assessed lung inflammation following MDSC depletion or adoptive transfer of MDSCs.

Main Results:

  • Mice with renal I/R injury and older mice showed increased MDSCs and more severe lung inflammation after poly(I:C) challenge.
  • Depletion of MDSCs significantly reduced lung inflammation in these mice.
  • Transferring MDSCs worsened poly(I:C)-induced lung inflammation.

Conclusions:

  • Elevated myeloid-derived suppressor cells (MDSCs) exacerbate viral pneumonia-induced lung inflammation, particularly in contexts of renal I/R injury and aging.
  • MDSCs represent a potential therapeutic target for managing severe viral pneumonia.

Related Concept Videos